Romanian Journal of Rheumatology (Dec 2021)

Complete, refractory dysphagia in a dermatomyositis patient with positive anti-NXP-2 antibodies

  • Claudia Cobilinschi,
  • Cristian Cobilinschi,
  • Alexandra Constantinescu,
  • Ruxandra Ionescu,
  • Daniela Opris-Belinski

DOI
https://doi.org/10.37897/RJR.2021.4.7
Journal volume & issue
Vol. 30, no. 4
pp. 169 – 173

Abstract

Read online

Dermatomyositis (DM) is a rare autoimmune disorder defined by weakness of the striated muscles and a distinctive skin rash. Dysphagia is a serious symptom that can be difficult to manage, severely impacting quality of life and long-term survival. The aim of this report is to highlight a case of an anti-NXP-2 positive DM with severe dysphagia refractory to multiple therapies, including steroids, cyclophosphamide and intravenous immunoglobulins. Anti-NXP-2 autoantibodies indicate a specific disease phenotype adding severe muscle weakness, dysphagia, peripheral edema and underlying malignancy.

Keywords